Cybin's Acquisition Of Small Pharma Will Elevate DMT Therapeutics For Depression And Anxiety
Psychedelics biotechCybin(NYSE:CYBN) and UK-basedSmall Pharma(OTC:DMTTF) announced their definitive arrangement agreement for Cybin's acquisition of all Small Pharma's issued and outstanding securities.
The deal has already been unanimously approved by both companies' board of directors and will next face Cybin's shareholders meeting on or about October 12.Read more HERE.
Second Psychedelics Merger Of The Week: Silo Wellness To Buy Jamaica-Based Business For $31.9M
Silo Wellness (OTC:SILFF) has confirmed its intention to acquire all issued and outstanding...
Login or create a forever free account to read this news
Sign up/Log in